高级检索
当前位置: 首页 > 详情页

Zinc Finger Protein Gfi1 Controls the Endotoxin-Mediated Toll-Like Receptor Inflammatory Response by Antagonizing NF-kappa B p65

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada [2]Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3T 3J7, Canada [3]Capital Med Univ, Beijing Tongren Hosp, Dept Respirat, Beijing 100730, Peoples R China [4]Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA [5]Capital Med Univ, Beijing Ditan Hosp, Inst Infect Dis, Beijing 100015, Peoples R China [6]Univ Klinikum Essen, Inst Zellbiol Tumorforsch, D-45122 Essen, Germany
出处:
ISSN:

摘要:
Endotoxin (bacterial lipopolysaccharide [LPS]) causes fatal septic shock via the Toll-like receptor 4 (TLR-4) protein present on innate immunity effector cells, which activates nuclear factor kappa B (NF-kappa B), inducing proinflammatory cytokines, including tumor necrosis factor alpha (TNF-alpha). An early step in this process involves nuclear sequestration of the p65-RelA NF-kappa B subunit, enabling transcriptional activation of target inflammatory cytokine genes. Here, we analyzed the role of the nuclear zinc finger protein Gfi1 in the TLR response using primary bone marrow-derived macrophages. We show that upon LPS stimulation, expression of Gfi1 is induced with kinetics similar to those of nuclear translocation of p65 and that Gfi1 interacts with p65 and inhibits p65-mediated transcriptional transactivation by interfering with p65 binding to target gene promoter DNA. Gfi1-deficient macrophages show abnormally high mRNA levels of the TNF-alpha gene and many other p65 target genes and a higher rate of TNF promoter occupancy by p65 than wild-type cells after LPS stimulation, suggesting that Gfi1 functions as an antagonist of NF-kappa B activity at the level of promoter binding. Our findings identify a new function of Gfi1 as a general negative regulator of the endotoxin-initiated innate immune responses, including septic shock and possibly other severe inflammatory diseases.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2009]版:
大类 | 2 区 生物
小类 | 2 区 生化与分子生物学 3 区 细胞生物学
最新[2023]版:
大类 | 2 区 生物学
小类 | 3 区 生化与分子生物学 3 区 细胞生物学
JCR分区:
出版当年[2008]版:
Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Q1 CELL BIOLOGY
最新[2023]版:
Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Q3 CELL BIOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2008版] 出版当年五年平均 出版前一年[2007版] 出版后一年[2009版]

第一作者:
第一作者机构: [1]Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada
通讯作者:
通讯机构: [1]Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada [2]Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3T 3J7, Canada [6]Univ Klinikum Essen, Inst Zellbiol Tumorforsch, D-45122 Essen, Germany [*1]Inst Rech Clin Montreal, 110 Ave Pins Ouest, Montreal, PQ H2W 1R7, Canada
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:21169 今日访问量:0 总访问量:1219 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)